Predictive value of early and late residual F-18-fluorodeoxyglucose and F-18-fluorothymidine uptake using different SUV measurements in patients with non-small-cell lung cancer treated with erlotinib

C. Kobe, M. Scheffler, A. Holstein, T. Zander, L. Nogova, A.A. Lammertsma, R. Boellaard, B. Neumaier, R.T. Ullrich, M. Dietlein, J. Wolf, D. Kahraman

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1117-1127
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume39
Issue number7
DOIs
Publication statusPublished - 2012

Cite this